🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the service has taken down problematic content and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also found groups with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.

Within moments of entering one group, a seller posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for Telegram stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to possibly serious medical dangers”.